According to a recent LinkedIn post from Cleerly, the company is promoting a Heart Month webinar focused on women’s heart health, featuring preventive cardiologist Dr. Suzanne Steinbaum. The session is described as covering sex-specific disease risk, the role of plaque, diagnostic limitations, and the potential for advancing equity through data in coronary artery disease care.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post suggests that Cleerly continues to position its AI-enabled CT and digital health capabilities within evidence-based, clinically relevant discussions on coronary artery disease. For investors, this type of educational outreach may support brand visibility among cardiology professionals, potentially aiding long-term commercial adoption, but the post itself does not provide direct information on revenue, customer growth, or new product launches.